Nifedipine suppresses self-injurious behaviors in animals

Developmental Neuroscience

Volumn 29, Issue 3, 2007, Pages 241-250

  Blake, Bonita L ^a   Muehlmann, Amber M ^b   Egami, Kiyoshi ^c   Breese, George R ^a   Devine, Darragh P ^b   Jinnah, H A ^c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of Florida ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Behavior, self injurious; Nifedipine; Therapy

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DESIPRAMINE; DILTIAZEM; DOPAMINE RECEPTOR STIMULATING AGENT; METHAMPHETAMINE; NIFEDIPINE; NIMODIPINE; NITRENDIPINE; PEMOLINE; SEDATIVE AGENT; VERAPAMIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMUTILATION; BIOLOGICAL ACTIVITY; BRAIN DEVELOPMENT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; FEMALE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEDATION;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; FEMALE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NIFEDIPINE; OXIDOPAMINE; PEMOLINE; PREGNANCY; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; SELF-INJURIOUS BEHAVIOR; SYMPATHOLYTICS;

EID: 33847626563     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096414     Document Type: Article

References (35)

1. Anderson LT, Ernst M (1994): Self-injury in Lesch-Nyhan disease. J Autism Dev Disord 24:67-81.
2. Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA (1984): Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 231:343-354.
3. Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL (2004): The neonate 6-hydroxydopamine lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Rev 48:57-73.
4. 1 dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J Neurosci 9:125-133.
5. Cromwell HC, Levine MS, King BS (1999): Cortical damage enhances pemoline-induced self-injurious behavior in prepubertal rats. Pharmacol Biochem Behav 62:223-227.
6. Dickson PR, Lang CG, Hinton SC, Kelley AE (1994): Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 61:81-91.
7. Halladay AK, Kusnecov A, Hichna L, Kita T, Hara C, Wagner CC (2003): Relationship between methamphetamine-induced dopamine release, hyperthermia, self-injurious behavior and long-term dopamine depletion in BALB/c and C57BL/6 mice. Pharmacol Toxicol 93:33-41.
8. V1.2 isoforms. Neuroscience 139:1005-1015.
9. Huberman HS, Eison MS, Bryan KS, Ellison G (1977): A slow-release silicone pellet for chronic amphetamine administration. Eur J Pharmacol 45:237-242.
10. Jinnah HA, Egami K, Rao K, Shin MY, Kasim S, Hess EJ (2004): Expression of c-fos in the brain after activation of L-type calcium channels. Dev Neurosci 25:403-411.
11. Jinnah HA, Gage FH, Friedmann T (1990): Animal models of Lesch-Nyhan syndrome. Brain Res Bull 25:467-475.
12. Jinnah HA, Yitta S, Drew T, Kim BS, Visser JE, Rothstein JD (1999): Calcium channel activation and self-biting in mice. Proc Natl Acad Sci USA 96:15228-15232.
13. Kasim S, Blake BL, Fan X, Chartoff EH, Egami K, Breese GR, Hess EJ, Jinnah HA: The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in mice. Dev Neurosci, in press.
14. Kasim S, Egami K, Jinnah HA (2002): Self-biting induced by activation of L-type calcium channels in mice: serotonergic influences. Dev Neurosci 24:322-327.
15. Kasim S, Jinnah HA (2002): Thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease. Pharmacol Biochem Behav 73:583-592.
16. Kasim S, Jinnah HA (2003): Self-biting induced by activation of L-type calcium channels in mice: dopaminergic influences. Dev Neurosci 25:20-25.
17. Kelley AE, Gauthier AM, Lang CG (1989): Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior. Behav Brain Res 35:24-39.
18. Kelley AE, Lang CG, Gauthier AM (1988): Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology 95:556-559.
19. Kies S, Devine DP (2004): Self-injurious behavior: a comparison of caffeine and pemoline in rats. Pharmacol Biochem Behav 79:587-598.
20. King BH, Au D, Poland RE (1995): Pretreatment with MK-801 inhibits pemoline-induced self-biting behavior in prepubertal rats. Dev Neurosci 17:47-52.
21. King BH, Cromwell HC, Lee HT, Behrstock SP, Schmanke T, Maidment NT (1998): Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Dev Neurosci 20:180-187.
22. Kita T, Matsunari Y, Saraya T, Shimada K, O'Hara K, Kubo K, Wagner GC, Nakashima T (2000): Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice. Int J Dev Neurosci 18:521-560.
23. Kratofil PH, Baberg HT, Dimsdale JE (1996): Self-mutilation and severe self-injurious behavior associated with amphetamine psychosis. Gen Hosp Psychiatry 18:117-120.
24. Luchins DJ (1991): A review of pharmacological agents for self-injurious behavior. Prog Neuropsychopharmacol Biol Psychiatry 14:S169-S179.
25. McDonough M, Hillery J, Kennedy N (2000): Olanzepine for chronic, stereotypic self-injurious behaviour: a pilot study in seven adults with intellectual disability. J Intellect Disabil Res 44:677-684.
26. Mueller K, Hollingsworth E, Pettit H (1986): Repeated pemoline produces self-injurious behavior in adult and weanling rats. Pharmacol Biochem Behav 25:933-938.
27. Mueller K, Nyhan WL (1982): Pharmacologic control of pemoline-induced self-injurious behavior in rats. Pharmacol Biochem Behav 16:957-963.
28. Mueller K, Saboda S, Palmour R, Nyhan WL (1982): Self-injurious behavior produced in rats by daily caffeine and continuous amphetamine. Pharmacol Biochem Behav 17:613-617.
29. 1 dopamine receptor agonist administration: implications for NMDA receptor involvement. J Neurosci 26:5863-5876.
30. Robey KL, Reck JF, Giacomini KD, Barabas G, Eddey GE (2003): Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease. Dev Med Child Neurol 45:167-171.
31. Schretlen DS, Ward J, Meyer SM, Yun J, Puig JG, Nyhan WL, Jinnah HA, Harris JC (2005): Behavioral aspects of Lesch-Nyhan disease and its variants. Dev Med Child Neurol 47:673-677.
32. Schroeder SR, Oster-Granite ML, Berkson G, Bodfish JW, Breese GR, Cataldo MF, Cook EH, Crnic LS, Fisher W, Harris JC, Horner RH, Iwata B, Jinnah HA, King BH, Lauder JM, Lewis MH, Newell K, Nyhan WN, Rojahan J, Sackett GP, Sandman C, Symons F, Tessel RE, Thompson T, Wong DF (2001): Self-injurious behavior: gene, brain, behavior relationships. Ment Retard Dev Disabil Res Rev 7:3-12.
33. Sokol MS, Campbell M, Goldstein M, Kriechman AM (1991): Attention deficit disorder with hyperactivity and the dopamine hypothesis: case presentations with theoretical background. J Am Acad Child Adolesc Psychiatry 26:428-433.
34. Symons FJ, Butler MG, Sander MD, Feurer ID, Thompson T (1999): Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am J Ment Retard 104:260-269.
35. Visser JE, Baer PR, Jinnah HA (2000): Lesch-Nyhan syndrome and the basal ganglia. Brain Res Brain Res Rev 32:449-475.